|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.920 USD | +7.64% |
|
+9.63% | +22.06% |
| Capitalization | 1.43B 1.24B 1.15B 1.07B 1.99B 130B 2.15B 13.23B 5.22B 62.04B 5.38B 5.27B 227B | P/E ratio 2025 * |
-4.64x | P/E ratio 2026 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise value | 1.43B 1.24B 1.15B 1.07B 1.99B 130B 2.15B 13.23B 5.22B 62.04B 5.38B 5.27B 227B | EV / Sales 2025 * |
0.92x | EV / Sales 2026 * | 0.89x |
| Free-Float |
89.77% | Yield 2025 * |
0.68% | Yield 2026 * | 0.68% |
More valuation ratios
* Estimated data
More news
Last Transcript: Diversified Healthcare Trust
More recommendations
More press releases
More news
| 1 day | +7.64% | ||
| 1 week | +9.63% | ||
| Current month | +22.06% | ||
| 1 month | +19.11% | ||
| 3 months | +45.45% | ||
| 6 months | +64.44% | ||
| Current year | +22.06% |
| 1 week | 5.28 | 6.04 | |
| 1 month | 4.62 | 6.04 | |
| Current year | 4.83 | 6.04 | |
| 1 year | 2 | 6.04 | |
| 3 years | 0.64 | 6.04 | |
| 5 years | 0.61 | 6.04 | |
| 10 years | 0.61 | 23.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 2023-12-31 | |
Matthew Brown
DFI | Director of Finance/CFO | 44 | 2023-09-30 |
Lindsey A. Getz
SEC | Corporate Secretary | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Adam Portnoy
CHM | Chairman | 55 | 2018-12-31 |
Jeffrey Somers
BRD | Director/Board Member | 83 | 2009-01-29 |
Lisa Jones
BRD | Director/Board Member | 58 | 2015-09-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +7.64% | +9.63% | +188.78% | +718.02% | 1.43B | ||
| +1.70% | +2.85% | +47.97% | +166.88% | 131B | ||
| +1.99% | +4.74% | +33.19% | +59.81% | 36.85B | ||
| +0.54% | +1.02% | +19.70% | +57.80% | 13.22B | ||
| +2.19% | +6.70% | -14.20% | -34.01% | 12.39B | ||
| +0.06% | +1.54% | +72.08% | - | 8.55B | ||
| +0.77% | +1.15% | +41.26% | +94.24% | 8.43B | ||
| +0.70% | +0.70% | +4.73% | -17.89% | 6.07B | ||
| +1.00% | -0.21% | +13.58% | +45.32% | 4.8B | ||
| +0.19% | +4.70% | +36.91% | +121.55% | 4.73B | ||
| Average | +1.68% | +3.19% | +44.40% | +134.63% | 22.78B | |
| Weighted average by Cap. | +1.57% | +3.08% | +39.99% | +123.02% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1.55B 1.34B 1.24B 1.16B 2.16B 141B 2.32B 14.32B 5.65B 67.13B 5.82B 5.7B 245B | 1.61B 1.39B 1.29B 1.2B 2.24B 146B 2.41B 14.84B 5.85B 69.58B 6.03B 5.9B 254B |
| Net income | -310M -267M -249M -231M -431M -28.1B -464M -2.86B -1.13B -13.41B -1.16B -1.14B -48.95B | -134M -115M -107M -99.88M -186M -12.13B -200M -1.23B -487M -5.79B -501M -491M -21.13B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
-
Sector
Specialized REITs
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-16 | 5.920 $ | +7.64% | 4,907,250 |
| 26-01-15 | 5.500 $ | +2.80% | 1,159,864 |
| 26-01-14 | 5.350 $ | -0.37% | 733,374 |
| 26-01-13 | 5.370 $ | -1.10% | 709,051 |
| 26-01-12 | 5.430 $ | +0.56% | 1,200,138 |
Delayed Quote Nasdaq, January 16, 2026 at 04:00 pm EST
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
5.920USD
Average target price
5.750USD
Spread / Average Target
-2.87%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DHC Stock
Select your edition
All financial news and data tailored to specific country editions
















